AstraZeneca's push into CAR-T therapies for cancer has continued with an agreement to take full control of C-CAR031, an anti-GPC3 therapy for solid tumours, from AbelZeta. In the latest development, ...
The Southern California company’s hypercar represents the future as well as utter madness in automotive form. Gah.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results